Greenwich Lifesciences, Inc. (GLSI)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$15.95+2.05%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · GLSI
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Worth watching into the next print: this name operates in a high-miss-rate industry and has been missing across recent quarters. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 398 industry peers · Company calendar date is not available
Review the full earnings evidenceWhy it matters: If revenue growth picks up, it could signal a positive shift in the sector's maturity phase.
Supportive ifRevenue growth speeds up again. It is above 10%.
Worry ifRevenue growth continues to slow or remains below 10%.
Why it matters: If healthcare revenue growth speeds up, it could signal a positive shift for GLSI.
Supportive ifHealthcare revenue growth is speeding up again. It is now above 9%.
Worry ifHealthcare revenue growth is slowing down. It is now below 9%.
Why it matters: If sector revenue growth drops, it could hurt Greenwich Lifesciences. The company is already losing money, and this could make it worse.
Worry ifSector revenue growth reported below its median level.
Less concerning ifSector revenue growth remains above its median level.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$275 on $10,000 · ±2.8% | How much price usually moves either way. |
| Bad day | $1,132 loss on $10,000 · 11.3% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $6,187 loss on $10,000 · 61.9% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.